Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials
Author:
Affiliation:
1. Department of Internal Medicine, Yale Cancer Center , New Haven, CT, USA
2. Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute , Bethesda, MD, USA
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djac212/47773967/djac212.pdf
Reference16 articles.
1. Testing in a prespecified subgroup and the intent-to-treat population;Rothmann;Drug Inf J,2012
2. Biomarker enrichment strategies: matching trial design to biomarker credentials;Freidlin;Nat Rev Clin Oncol,2014
3. A problematic biomarker trial design;Freidlin;J Natl Cancer Inst,2022
4. Flawed trials for cancer;Tannock;Ann Oncol,2020
5. Nested and adjacent subgroups in cancer clinical trials: when the best interests of companies and patients diverge;Kim;Eur J Cancer,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review of trials investigating ctDNA-guided adjuvant treatment of solid tumors: The importance of trial design;European Journal of Cancer;2024-08
2. Development of a monoclonal antibody to ITPRIPL1 for immunohistochemical diagnosis of non-small cell lung cancers: accuracy and correlation with CD8+ T cell infiltration;Frontiers in Cell and Developmental Biology;2023-12-19
3. Gegen Nectin-4 gerichtete Antikörper-Wirkstoff-Konjugate als neue Behandlungsoption für Patienten mit metastasiertem Urothelkarzinom;Die Urologie;2023-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3